BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32547063)

  • 1. Long Noncoding RNAs in Diffuse Large B-Cell Lymphoma: Current Advances and Perspectives.
    Huang X; Qian W; Ye X
    Onco Targets Ther; 2020; 13():4295-4303. PubMed ID: 32547063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma.
    Verma A; Jiang Y; Du W; Fairchild L; Melnick A; Elemento O
    Genome Med; 2015 Nov; 7():110. PubMed ID: 26521025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Coding RNAs in Diffuse Large B-Cell Lymphoma.
    Shi Y; Ding D; Qu R; Tang Y; Hao S
    Onco Targets Ther; 2020; 13():12097-12112. PubMed ID: 33262609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research on Ralation of Long Non-coding RNA with Diffuse Large B-cell Lymphomas -Review].
    Wu YY; Xing YR; Yu DN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):609-614. PubMed ID: 29665941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma.
    Peng W; Wu J; Feng J
    Biomed Pharmacother; 2016 Apr; 79():188-93. PubMed ID: 27044827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive analysis of long non-coding RNA expression profiles in diffuse large B-cell lymphoma.
    Zhu D; Fang C; Li X; Geng Y; Li R; Wu C; Jiang J; Wu C
    Oncotarget; 2017 Apr; 8(14):23228-23236. PubMed ID: 28423571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs expression levels in diffuse large B-cell lymphoma: An in silico analysis.
    Dousti F; Shahrisa A; Ansari H; Hajjari M; Tahmasebi Birgani Y; Mohammadiasl J; Tahmasebi Birgani M
    Pathol Res Pract; 2018 Sep; 214(9):1462-1466. PubMed ID: 30104077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity.
    Peng W; Fan H; Wu G; Wu J; Feng J
    Clin Exp Med; 2016 May; 16(2):177-82. PubMed ID: 25864113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Non-Coding RNAs in Diffuse Large B-Cell Lymphoma.
    Karstensen KT; Schein A; Petri A; Bøgsted M; Dybkær K; Uchida S; Kauppinen S
    Noncoding RNA; 2020 Dec; 7(1):. PubMed ID: 33379241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway.
    Wang Y; Zhang M; Xu H; Wang Y; Li Z; Chang Y; Wang X; Fu X; Zhou Z; Yang S; Wang B; Shang Y
    Oncotarget; 2017 Sep; 8(42):72182-72196. PubMed ID: 29069778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma.
    Gao HY; Wu B; Yan W; Gong ZM; Sun Q; Wang HH; Yang W
    Oncol Rep; 2017 Sep; 38(3):1363-1372. PubMed ID: 28713985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma.
    Peng W; Feng J
    Biomed Pharmacother; 2016 Feb; 77():65-71. PubMed ID: 26796267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in diffuse large B-cell lymphoma.
    Ni H; Tong R; Zou L; Song G; Cho WC
    Oncol Lett; 2016 Feb; 11(2):1271-1280. PubMed ID: 26893730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
    Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
    Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of differentially expressed profiles of lncRNAs and mRNAs reveals ceRNA networks in the transformation of diffuse large B-cell lymphoma.
    Tian L; He Y; Zhang H; Wu Z; Li D; Zheng C
    Oncol Lett; 2018 Jul; 16(1):882-890. PubMed ID: 29963159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pooled Analysis of The Clinical Utilities of Long Non-Coding RNA Based Molecular Signature for Diffuse Large B Cell Lymphoma.
    Xu P; Chen X; Su P
    Clin Lab; 2017 Nov; 63(11):1831-1840. PubMed ID: 29226652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization.
    Cascione L; Giudice L; Ferraresso S; Marconato L; Giannuzzi D; Napoli S; Bertoni F; Giugno R; Aresu L
    Noncoding RNA; 2019 Sep; 5(3):. PubMed ID: 31546795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging roles for long noncoding RNAs in B-cell development and malignancy.
    Winkle M; Kluiver JL; Diepstra A; van den Berg A
    Crit Rev Oncol Hematol; 2017 Dec; 120():77-85. PubMed ID: 29198340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.